Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma

被引:179
作者
Kendall, BS
Ronnett, BM
Isacson, C
Cho, KR
Hedrick, L
Diener-West, M
Kurman, RJ
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol & Gynecol Obstet, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD 21287 USA
关键词
endometrial carcinoma; endometrial hyperplasia; atypical hyperplasia; reproducibility;
D O I
10.1097/00000478-199808000-00012
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Many studies have attempted to identify histologic features that aid in the distinction of atypical hyperplasia (AH) from hyperplasia without atypia and well-differentiated endometrioid carcinoma, but few have evaluated the reproducibility of these diagnoses. Five pathologists independently reviewed 100 endometrial biopsy and curettage specimens chosen to represent the entire spectrum of proliferative lesions of the endometrium, including proliferative endometrium (PEM), hyperplasia without atypia, AH, and well-differentiated endometrioid carcinoma. Slides were reviewed twice for diagnosis, with an intervening evaluation of a checklist of histologic features. Intraobserver and interobserver agreement were assessed using the kappa statistic. Intraobserver kappa values ranged from 0.67 to 0.89 (76% to 89% agreement). Interobserver kappa values by diagnostic category were: proliferative endometrium: 0.86; hyperplasia without atypia: 0.60; AH: 0.47; well-differentiated endometrioid carcinoma: 0.83; with a kappa value of 0.69 for all cases combined. Associations between the selected histologic features and the given diagnoses for each pathologist were analysed using multiple logistic regressions to identify features that were useful for distinguishing among diagnostic categories. Histologic features determined by univariable and multivariable analyses that were found to be most associated with distinguishing diagnostic categories were: proliferative endometrium versus hyperplasia without atypia: gland crowding (univariable, multivariable), and gland branching (univariable); hyperplasia without atypia versus AH: presence of nucleoli (univariable, multivariable), nuclear enlargement (univariable), vesicular chromatin change (univariable), nuclear pleomorphism (univariable), chromatin irregularities (univariable), and lass of polarity (univariable); hyperplasia without atypia versus carcinoma: glandular confluence/complex cribriform pattern (univariable, multivariable), stromal alteration (univariable, multivariable), and necrosis (univariable). In summary, interobserver agreement was good but was lowest for AH. Only the presence of nucleoli was strongly associated with distinction of AH from hyperplasia without atypia, Individual pathologists use additional features to diagnose atypia, but these features are not consistently associated with that diagnosis. Cribriform architectural pattern and stromal alteration were associated with the distinction of well-differentiated endometrioid carcinoma from AH.
引用
收藏
页码:1012 / 1019
页数:8
相关论文
共 50 条
  • [1] Determining the Inter- and Intraobserver Reproducibility of the Diagnosis of Endometrial Hyperplasia Subgroups and Well-Differentiated Endometrioid Carcinoma in Endometrial Curettage Specimens
    Izadi-Mood, Narges
    Khaniki, Mahmood
    Irvanloo, Guity
    Ahmadi, Seyed-Ali
    Hayeri, Hayedeh
    Meysamie, Alipasha
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (04) : 377 - 382
  • [2] Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins
    Wheeler, Darren T.
    Bristow, Robert E.
    Kurman, Robert J.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (07) : 988 - 998
  • [3] Fractal Dimension as a Diagnostic Tool of Complex Endometrial Hyperplasia and Well-differentiated Endometrioid Carcinoma
    Bikou, Olga
    Delides, Alexander
    Drougou, Aggeliki
    Nonni, Afroditi
    Patsouris, Efstratios
    Pavlakis, Kitty
    IN VIVO, 2016, 30 (05): : 681 - 690
  • [4] Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium
    Yu, Mei
    Yang, Jia-xin
    Wu, Ming
    Lang, Jing-he
    Huo, Zhen
    Shen, Keng
    FERTILITY AND STERILITY, 2009, 92 (06) : 2122 - 2124
  • [5] Multifractal Spectrum Differentiation of Well-Differentiated Adenocarcinoma from Complex Atypical Hyperplasia of the Uterus
    Barwad, Adarsh
    Dey, Pranab
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2012, 34 (02): : 105 - 108
  • [6] PROPOSED CRITERIA FOR THE DIAGNOSIS OF WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA - A DIAGNOSTIC-TEST FOR MYOINVASION
    LONGACRE, TA
    CHUNG, MH
    JENSEN, DN
    HENDRICKSON, MR
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (04) : 371 - 406
  • [7] Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins
    Witkiewicz, Agnieszka K.
    McConnell, Thomas
    Potoczek, Magdalena
    Emmons, Robert V. B.
    Kurman, Robert J.
    HUMAN PATHOLOGY, 2010, 41 (01) : 26 - 32
  • [8] Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia
    Hahn, Ho-Suap
    Chun, Yi-Kyeong
    Kwon, Yong-Il
    Kim, Tae-Jin
    Lee, Ki-Heon
    Shim, Jae-Uk
    Mok, Jung-Eun
    Lim, Kyung-Taek
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 150 (01) : 80 - 83
  • [9] Problems in the differential diagnosis of endometrial hyperplasia and carcinoma
    Silverberg, SG
    MODERN PATHOLOGY, 2000, 13 (03) : 309 - 327
  • [10] Reproducibility determination of WHO classification of endometrial hyperplasia/well differentiated adenocarcinoma and comparison with computerized morphometric data in curettage specimens in Iran
    Narges Izadi-Mood
    Maryam Yarmohammadi
    Seyed Ali Ahmadi
    Guity Irvanloo
    Hayedeh Haeri
    Ali Pasha Meysamie
    Mahmood Khaniki
    Diagnostic Pathology, 4